• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将知名药物重新用于抗病毒治疗:羟氯喹和氯喹——从 HIV-1 感染到 COVID-19。

Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.

机构信息

Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences , Mashhad, Iran.

出版信息

Expert Rev Anti Infect Ther. 2020 Nov;18(11):1119-1133. doi: 10.1080/14787210.2020.1792291. Epub 2020 Jul 13.

DOI:10.1080/14787210.2020.1792291
PMID:32631083
Abstract

INTRODUCTION

Chloroquine (CQ) and hydroxychloroquine (HCQ) originally were prescribed for prevention or treatment of malaria, but now successfully are used in several rheumatologic diseases. In addition, in recent decades considering their immunomodulatory effects, high tolerably, and low cost, they are evaluated for various viral infections from HIV to COVID-19.

AREAS COVERED

In this review, we tried to summarize all available studies on HCQ and CQ efficacy for management of viral infections and the probable mechanisms of action. The data were collected by searching 'Hydroxychloroquine,' 'Chloroquine,' 'Viral infection,' and names of various viral infections in PubMed/MEDLINE, Scopus, and Google Scholar databases from commencement to June 2020. Out of 95 search results, 74 most relevant works were gathered.

EXPERT OPINION

HCQ/CQ showed acceptable efficacy in HIV especially as an adjuvant treatment beside routine HAART. However, for some viral infections such as ZIKA, EBOLA, SARS-CoV, and MERS-CoV, human studies are lacking. In the COVID-19 pandemic, in vitro and preliminary human studies showed encouraging findings. However, later well-designed trials and retrospective studies with large sample size not only reported non-significant efficacy but also showed more cardiac adverse reactions. Alkalinization of acid vesicles is the most important mechanism of action.

摘要

简介

氯喹(CQ)和羟氯喹(HCQ)最初用于预防或治疗疟疾,但现在已成功用于多种风湿性疾病。此外,近几十年来,由于其具有免疫调节作用、高耐受性和低成本,它们被评估用于从 HIV 到 COVID-19 的各种病毒感染。

涵盖领域

在这篇综述中,我们试图总结所有关于 HCQ 和 CQ 治疗病毒感染的有效性及其可能的作用机制的可用研究。数据通过在 PubMed/MEDLINE、Scopus 和 Google Scholar 数据库中搜索“Hydroxychloroquine”、“Chloroquine”、“Viral infection”和各种病毒感染的名称来收集,检索时间从开始到 2020 年 6 月。在 95 个搜索结果中,收集了 74 篇最相关的文献。

专家意见

HCQ/CQ 在 HIV 中显示出可接受的疗效,特别是作为常规 HAART 治疗的辅助治疗。然而,对于某些病毒感染,如寨卡病毒、埃博拉病毒、SARS-CoV 和 MERS-CoV,缺乏人体研究。在 COVID-19 大流行期间,体外和初步人体研究显示出令人鼓舞的结果。然而,后来设计良好的试验和大样本量的回顾性研究不仅报告了非显著疗效,而且还显示出更多的心脏不良反应。酸化囊泡的碱化是最重要的作用机制。

相似文献

1
Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.将知名药物重新用于抗病毒治疗:羟氯喹和氯喹——从 HIV-1 感染到 COVID-19。
Expert Rev Anti Infect Ther. 2020 Nov;18(11):1119-1133. doi: 10.1080/14787210.2020.1792291. Epub 2020 Jul 13.
2
Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.重新利用氯喹和羟氯喹作为抗病毒药物的临床证据:系统评价。
Clin Microbiol Infect. 2020 Aug;26(8):979-987. doi: 10.1016/j.cmi.2020.05.016. Epub 2020 May 26.
3
A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic.关于氯喹/羟氯喹可能作用模式的综述:重新用于对抗 SAR-CoV-2(COVID-19)大流行。
Int J Antimicrob Agents. 2020 Aug;56(2):106028. doi: 10.1016/j.ijantimicag.2020.106028. Epub 2020 May 22.
4
COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.新型冠状病毒肺炎疫情:氯喹和羟氯喹潜在作用的叙事性综述。
Pain Physician. 2020 Aug;23(4S):S351-S366.
5
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.氯喹和羟氯喹在疟疾治疗中的应用和在 COVID-19 治疗中的再利用。
Pharmacol Ther. 2020 Dec;216:107672. doi: 10.1016/j.pharmthera.2020.107672. Epub 2020 Sep 8.
6
[Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].[羟氯喹和氯喹治疗新冠病毒病:无有效性证据]
Ned Tijdschr Geneeskd. 2020 Jun 2;164:D5141.
7
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?4-氨基喹啉类药物(氯喹/羟氯喹)抗 SARS-CoV-2 感染(COVID-19)的可能作用机制:铁稳态的作用?
Pharmacol Res. 2020 Aug;158:104904. doi: 10.1016/j.phrs.2020.104904. Epub 2020 May 13.
8
Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.氯喹和羟氯喹在治疗 COVID-19 中的应用进展。
Postgrad Med. 2020 Sep;132(7):604-613. doi: 10.1080/00325481.2020.1778982. Epub 2020 Jun 21.
9
Janus sword actions of chloroquine and hydroxychloroquine against COVID-19.氯喹和羟氯喹对 COVID-19 的扬努斯剑作用。
Cell Signal. 2020 Sep;73:109706. doi: 10.1016/j.cellsig.2020.109706. Epub 2020 Jul 3.
10
Of chloroquine and COVID-19.关于氯喹和 COVID-19。
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.

引用本文的文献

1
Efficacy and Safety of Remdesivir in Hospitalized Pediatric COVID-19: A Retrospective Case-Controlled Study.瑞德西韦治疗住院儿童 COVID-19 的疗效和安全性:一项回顾性病例对照研究。
Ther Clin Risk Manag. 2023 Nov 23;19:949-958. doi: 10.2147/TCRM.S432565. eCollection 2023.
2
The effects of hydroxychloroquine and its promising use in refractory obstetric antiphospholipid syndrome.羟氯喹及其在难治性产科抗磷脂综合征中的应用前景。
Rheumatol Int. 2024 Feb;44(2):223-234. doi: 10.1007/s00296-023-05457-5. Epub 2023 Sep 23.
3
Small molecules targeting endocytic uptake and recycling pathways.
靶向内吞摄取和再循环途径的小分子。
Front Cell Dev Biol. 2023 Mar 10;11:1125801. doi: 10.3389/fcell.2023.1125801. eCollection 2023.
4
Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid.碱性药物在溶酶体中的亚细胞隔离:溶酶体液药物开发的新见解。
Res Pharm Sci. 2022 Dec 24;18(1):1-15. doi: 10.4103/1735-5362.363591. eCollection 2023 Feb.
5
Hydroxychloroquine Alleviates EAU by Inhibiting Uveitogenic T Cells and Ameliorating Retinal Vascular Endothelial Cells Dysfunction.羟氯喹通过抑制致葡萄膜炎 T 细胞和改善视网膜血管内皮细胞功能障碍缓解 EAU。
Front Immunol. 2022 Mar 25;13:859260. doi: 10.3389/fimmu.2022.859260. eCollection 2022.
6
Can anti-parasitic drugs help control COVID-19?抗寄生虫药物能帮助控制新冠病毒吗?
Future Virol. 2022 Mar. doi: 10.2217/fvl-2021-0160. Epub 2022 Mar 18.
7
Multipurpose Drugs Active Against Both spp. and Microorganisms: Potential Application for New Drug Development.多功能药物,既能有效对抗 spp.,也能抑制微生物:新药研发的潜在应用。
Front Cell Infect Microbiol. 2021 Dec 24;11:797509. doi: 10.3389/fcimb.2021.797509. eCollection 2021.
8
How to exploit different endocytosis pathways to allow selective delivery of anticancer drugs to cancer cells over healthy cells.如何利用不同的内吞途径,实现抗癌药物相对于健康细胞选择性地递送至癌细胞。
Chem Sci. 2021 Nov 18;12(46):15407-15417. doi: 10.1039/d1sc04656j. eCollection 2021 Dec 1.
9
Mechanism of Blood-Heart-Barrier Leakage: Implications for COVID-19 Induced Cardiovascular Injury.血心屏障渗漏机制:对 COVID-19 引起的心血管损伤的影响。
Int J Mol Sci. 2021 Dec 17;22(24):13546. doi: 10.3390/ijms222413546.
10
Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.瑞德西韦和 EIDD-1931 与人平衡核苷转运蛋白 1 和 2 相互作用:到达 SARS-CoV-2 病毒避难所的意义。
Mol Pharmacol. 2021 Dec;100(6):548-557. doi: 10.1124/molpharm.121.000333. Epub 2021 Sep 9.